ANSM — authorised 1 December 2005
- Marketing authorisation holder: Roche Registration Limited
- Status: approved
ANSM authorised Bevacizumab on 1 December 2005
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. ANSM authorised it on 1 December 2005.
Roche Registration Limited holds the French marketing authorisation.